<?xml version="1.0" encoding="UTF-8"?>
<ref id="B35-antioxidants-09-01273">
 <label>35.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Nandagopal</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Halder</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Dash</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Nayak</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Jha</surname>
    <given-names>S.</given-names>
   </name>
  </person-group>
  <article-title>Biotechnological approaches for production of anti-cancerous compounds resveratrol, podophyllotoxin and zerumbone</article-title>
  <source>Curr. Med. Chem.</source>
  <year>2018</year>
  <volume>25</volume>
  <fpage>4693</fpage>
  <lpage>4717</lpage>
  <pub-id pub-id-type="doi">10.2174/0929867324666170404145656</pub-id>
  <?supplied-pmid 28393691?>
  <pub-id pub-id-type="pmid">28393691</pub-id>
 </element-citation>
</ref>
